COVIRTUA Healthcare

Name

COVIRTUA Healthcare

Legal name

COVIRTUA Healthcare SAS

Website

https://covirtua.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Digital Cognitive Rehabilitation Therapeutics

NAICS

Outpatient Mental Health and Substance Abuse Centers (621420), Home Health Care Services (621610)

SIC

Services-Misc Health & Allied Services, Nec (8090), Services-Home Health Care Services (8082)

akta.pro primary industry

Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)

akta.pro secondary industries

Virtual Nursing, Telemonitoring & Command Center Platforms (HLACAFAH), Integrated Behavioral Health (Collaborative Care) Platforms (HLALAEAC)

Keywords

• Cognitive rehabilitation therapy
• Digital medical devices
• Virtual reality therapy
• Neurological rehabilitation software
• Tele-rehabilitation platform

Headquarters

HQ city

Colomiers

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. COVIRTUA Cognition SaaS Subscription: COVIRTUA Healthcare operates as a subscription-based SaaS model for its COVIRTUA Cognition digital therapy platform. Healthcare facilities and therapists pay recurring subscription fees. Subscription terms are 12 months for liberal therapists and 36 months for healthcare establishments, both with tacit renewal.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

COVIRTUA Healthcare develops and sells COVIRTUA Cognition®, a CE Class I medical device delivered as a cloud-based digital cognitive remediation therapy platform. The platform combines immersive virtual reality scenarios with analytical exercises targeting memory, attention, language, and executive functions, and operates through a dual-interface architecture (Therapist Application and Patient Application) that enables real-time collaborative therapy adjustment and remote tele-rehabilitation across hospital, clinic, and home settings.

Product overview

COVIRTUA Healthcare offers COVIRTUA Cognition® as its primary commercial product—a cloud-based cognitive remediation therapy platform combining virtual reality immersive scenarios with analytical cognitive exercises targeting memory, attention, language, and executive functions. The platform operates through dual interfaces: a therapist-facing web application (app.covirtua.com) and a patient-facing web application (seance.covirtua.com), enabling real-time collaborative adjustments during sessions and continued auto-rehabilitation between sessions. The product is designed for use across hospital, outpatient clinic, and home settings with telehealth capability. Future roadmap includes COVIRTUA Evaluation, a planned Class IIa diagnostic aid device for normed cognitive assessment. All solutions are developed in collaboration with neuroscience experts and medical teams, and data is stored on HDS-certified health data hosting infrastructure.

Differentiator

Problem solved

Functional benefit

Brands

• COVIRTUA Cognition®: A digital cognitive remediation therapy solution and CE Class I medical device for patients with cognitive disorders, featuring immersive and personalized rehabilitation exercises.
• COVIRTUA Evaluation

Products and services

• COVIRTUA Cognition® COVIRTUA Cognition® is a CE Class I medical device delivered as a cloud-based digital cognitive remediation therapy platform for healthcare professionals (orthophonists, neuropsychologists, ergotherapists, psychomotor therapists, physicians) and their patients. It combines immersive virtual reality scenarios with analytical cognitive exercises targeting memory, attention, language, and executive functions, and operates through a dual-interface architecture (Therapist Application at app.covirtua.com and Patient Application at seance.covirtua.com) enabling real-time collaborative therapy adjustment, tele-rehabilitation (télésoin), and home-based auto-rehabilitation across hospital, clinic, and home settings.

Quantifiable outcome

• COVIRTUA Cognition combined with transcranial stimulation improves executive functioning in daily life (e.g., planning shopping) for patients with frontal lobe lesions
• +3 more outcomes

Named customers13 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

25 partnerships are on record, tiered core, secondary and minor.

• CHU de BordeauxcoreStrategic or Co-development Partner · 1 January 2022CHU de Bordeaux's COLA unit (Cognition and Language) uses COVIRTUA Cognition for tele-rehabilitation. The team, including Dr Bertrand Glize, Mathilde Carlsberg, and orthophonists, implements remote cognitive rehabilitation protocols for patients with acquired brain lesions.
• Hospices Civils de LyoncoreStrategic or Co-development Partner · 1 January 2021Hospices Civils de Lyon established a clinical collaboration with COVIRTUA Healthcare under Professor Sophie Courtois for cognitive rehabilitation programs.
• CHU de MontpelliercoreStrategic or Co-development Partner · 1 January 2021CHU de Montpellier is a partner in the multi-center clinical study (PHRIP) funded by the Ministry of Health, measuring medico-economic gains of COVIRTUA Cognition on post-AVC patients. Also a partner in ESNbyUM digital health school.
• CHU de ToulousecoreStrategic or Co-development Partner · 1 January 2019CHU de Toulouse is a core strategic partner conducting clinical validation of COVIRTUA Cognition. The collaboration includes the MODEX project studying mental flexibility in brain-injured patients, involving researchers such as Pr Xavier de Boissezon and Dr Evelyne Castel-Lacanal. CHU de Toulouse is also a partner in the ESNbyUM digital health school project.
• CHU de LillecoreStrategic or Co-development Partner · 1 January 2019CHU de Lille conducted a preliminary validation study measuring psychometric properties of COVIRTUA Cognition exercises in patients with acquired cerebral lesions (stroke and traumatic brain injury). The study involved 30 patients and demonstrated good reproducibility and validity of the exercises.
• CNRScoreStrategic or Co-development PartnerCOVIRTUA Healthcare collaborates with CNRS (Centre National de la Recherche Scientifique) on multiple research projects including the NEMONOR project on noradrenaline and episodic memory, and cognitive training research. Researchers from CNRS units including CerCo, CLLE, and INCIA are involved in COVIRTUA-related studies.
• INSERMcoreStrategic or Co-development PartnerINSERM collaborates with COVIRTUA on multiple research projects including NEMONOR (noradrenaline and episodic memory in aging), MODEX (mental flexibility in brain-injured patients), and EVOLEX (voice recognition for language dysfunction diagnosis). Multiple INSERM teams including ToNIC, CerCo, and Octogone-Lordat are research partners.
• IRIT (Institut de Recherche en Informatique de Toulouse)coreTechnology or IntegrationIRIT is a key technology research partner contributing to COVIRTUA's software development and cognitive assessment tools. IRIT researchers are involved in projects including EVOLEX (voice recognition) and user accessibility studies for teleconsultation platforms.
• ESNbyUM (Ecole de Santé Numérique)coreStrategic or Co-development PartnerCOVIRTUA Healthcare is a partner in ESNbyUM, the digital health school created by the University of Montpellier. This school, funded by the government and the Occitanie Region (8 million euro budget), will train future healthcare professionals in digital health from 2023. COVIRTUA contributes pedagogical content for the program.
• ISAE-SUPAEROsecondaryStrategic or Co-development PartnerISAE-SUPAERO is a partner in the MODEX project developing rehabilitation programs for patients with frontal lobe lesions, contributing expertise in cognitive and motor task design.
• SuriCogsecondaryStrategic or Co-development PartnerSuriCog is a partner in the PREDICOG research project, which aims to identify predictive markers of cognitive decline using cognitive measurement tools and eye-tracking analysis.
• KORIANsecondaryChannel Partner/ Reseller/ DistributorKORIAN uses COVIRTUA Cognition across its rehabilitation and care facilities in French-speaking Europe.
• Ramsay Générale de SantésecondaryChannel Partner/ Reseller/ DistributorRamsay Générale de Santé uses COVIRTUA Cognition across its network of private healthcare facilities.
• UGECAMsecondaryChannel Partner/ Reseller/ DistributorUGECAM uses COVIRTUA Cognition within its rehabilitation facility network.
• MGENsecondaryChannel Partner/ Reseller/ DistributorMGEN integrates COVIRTUA Cognition within its mutual healthcare network.
• GH Caux MaritimesecondaryStrategic or Co-development PartnerGH Caux Maritime presented a validation study for COVIRTUA Cognition in psychiatry at the 5th Normandy Psychiatry Day, in partnership with Centre Hospitalier du Rouvray, CHU de Rouen, Institut de Psychiatrie, Fondation Pierre Deniker, Centre Cycéron, and CNRS.
• Association AVC, AIT Carpe DiemsecondaryStrategic or Co-development PartnerPatient association partner in the 'Paroles de Patients' video testimony series and collaborative research on teleconsultation accessibility for patients with cognitive disorders.
• Institut Universitaire des Sciences de la Réadaptation (IUSR), Université de BordeauxsecondaryStrategic or Co-development PartnerIUSR collaborated with CHU de Bordeaux to organize the 'Télérééducation: éclairages sur une évolution des pratiques de soin' day, where therapists shared their tele-rehabilitation experience with COVIRTUA.
• AstraZenecaminorGTM or Marketing PartnerAstraZeneca pharmaceutical laboratory provides support to COVIRTUA Healthcare in the theme of disability.
• CHIC Castres MazametsecondaryStrategic or Co-development PartnerCHIC Castres Mazamet is a partner in the COGIDO project, collaborating with CHU de Toulouse, Ages sans frontières, and IRIT on home-based cognitive training for elderly patients.
• Institut 3IA MIAI / Université Grenoble AlpessecondaryStrategic or Co-development PartnerCOVIRTUA collaborates with MIAI (Multidisciplinary Institute in Artificial Intelligence) and Université Grenoble Alpes on a CIFRE thesis project studying elderly patient engagement with cognitive training software to improve therapeutic adherence.
• Institut de Formation d'Ergothérapie (IFE) du CHU de ToulousesecondaryStrategic or Co-development PartnerCOVIRTUA co-developed with Jean-Michel Caire of IFE du CHU de Toulouse a pedagogical module on 'Virtual Reality and Cognitive Remediation', aligned with competencies 1, 3, 7, and 8 of the French State Diploma in Ergotherapy.
• Université de Bretagne OccidentaleminorStrategic or Co-development PartnerCOVIRTUA participates in the pedagogical content of the UBO Psychology Master's program.
• Haute Ecole Léonard de Vinci (Bruxelles)minorStrategic or Co-development PartnerCOVIRTUA integrates the pedagogical offerings of the Haute Ecole Léonard de Vinci in Brussels for the Ergotherapy program.
• August DebouzysecondaryOthersLaw firm August Debouzy advises COVIRTUA Healthcare on GDPR compliance, user information protection, and transparency.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Posit Science (BrainHQ): Commercial cognitive training platform with clinically validated exercises targeting memory, attention, and brain health. Comparable in offering computerized cognitive remediation exercises to older adults and clinical populations, including partnerships with health systems.
• Constant Therapy Health: US digital therapeutics company delivering evidence-based cognitive, speech, and language therapy for stroke and TBI patients via tablet. Highly comparable in clinical use case (post-stroke cognitive rehab) and B2B2C therapist-channel GTM, though without the VR immersion layer.
• MindMaze: Swiss-headquartered digital neurotherapeutics company offering VR-based rehabilitation for stroke, brain injury, and cognitive disorders. Closest direct competitor given overlap in immersive VR cognitive therapy, hospital channel, and CE-marked medical device positioning.
• XRHealth: US/Israel-based VR telehealth platform for physical therapy, cognitive therapy, and rehabilitation delivered remotely by licensed clinicians. Closely comparable in combining VR immersion, tele-rehabilitation, therapist interface, and regulated medical-device positioning.
• Cogstate: Australian-listed neuroscience technology company providing computerized cognitive assessment and digital brain health tools used in clinical trials, healthcare, and research. Overlaps with COVIRTUA's cognitive measurement roadmap (COVIRTUA Evaluation) and clinical validation GTM.

Emerging players

• Saebo: US-based rehabilitation technology company offering devices and digital tools for stroke and neurological recovery. Comparable target customer base (therapists and hospitals treating stroke survivors) though focused more on physical/upper-limb rehab than cognitive remediation.
• Penumbra (REAL Immersive System): US medical device company that launched the REAL Immersive System for at-home VR rehabilitation, including cognitive and motor exercises for stroke survivors. Overlaps with COVIRTUA's stroke/tele-rehab use case but operates with greater commercial scale.

Broad incumbents

• Akili Interactive: US digital therapeutics company (publicly listed via SPAC) developing FDA-cleared and CE-marked prescription digital therapeutics for cognitive conditions (ADHD, MS). Comparable as a broader digital therapeutics incumbent targeting regulatory-grade cognitive treatment pathways.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/covirtua
• Facebookfacebook.com/CovirtuaCognition
• LinkedInlinkedin.com/company/covirtua

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about COVIRTUA Healthcare